logo
INNOVIA : +962-64711910
Jordan, Amman, Qastal, Fawaz Mashhour Sattam info@innoviabiobank.com

Adult Acute Myelogenous Leukemia

The use of cord blood stem cells to treat acute myelogenous leukemia extends beyond children. In 2003, a 52-year-old mother of two sons was diagnosed with the disease and underwent two rounds of successful chemotherapy. However, her leukemia relapsed shortly after, prompting two bone marrow stem cell transplants in early 2004, both of which failed within weeks.

Following the second failed bone marrow transplant, she underwent a successful transplantation with matching cord blood stem cells a month later. Today, she enjoys a healthy life. Like other adults who have undergone similar transplants, her blood and immune system exhibit characteristics akin to those of a young child, and she reports faster healing from injuries compared to individuals of her age